<?xml version="1.0" encoding="iso-8859-1" ?>
<newsitem itemid="135958" id="root" date="1996-10-23" xml:lang="en">
<title>USA: Scios, Wyeth-Ayerst in deal.</title>
<headline>Scios, Wyeth-Ayerst in deal.</headline>
<dateline>MOUNTAIN VIEW, Calif 1996-10-23</dateline>
<text>
<p>Scios Inc and American Home Products Corp's Wyeth-Ayerst division agreed to develop and market Scios' FIBLAST trafermin for treatment of neurological and cardiovascular disorders.</p>
<p>FIBLAST is currently in Phase I/II clinical trials for stroke and coronary artery disease and in preclinical studies for peripheral vascular disease.  </p>
<p>Wyeth-Ayerst will make a $12 million upfront payment in cash and up to $32 million in milestone payments upon achievement of all key development events. It will also provide a $12 million line of credit that Scios may draw upon from time to time to fund expansion of its manufacturing facility for FIBLAST.</p>
<p>The total of all payments including the line of credit could reach $56 million, excluding shared development costs, royalties, supply payments and profit sharing.  </p>
<p>Under the terms of the agreement, Wyeth-Ayerst and Scios will collaborate in the development and commercialization of FIBLAST in North America, where the companies will share development costs and profits.</p>
<p>Scios has granted Wyeth-Ayerst exclusive marketing rights outside of North America and certain Pacific Rim countries and will receive royalties on sales outside of North America and payments for bulk drug supply worldwide.  </p>
<p>American Home Products currently owns 1,579,000 shares or 4.4 percent of Scios common stock.</p>
</text>
<copyright>(c) Reuters Limited 1996</copyright>
<metadata>
<codes class="bip:countries:1.0">
  <code code="USA">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1996-10-23"/>
  </code>
</codes>
<codes class="bip:industries:1.0">
  <code code="I25670">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1996-10-23"/>
  </code>
  <code code="I25700">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1996-10-23"/>
  </code>
</codes>
<codes class="bip:topics:1.0">
  <code code="C11">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1996-10-23"/>
  </code>
  <code code="C17">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1996-10-23"/>
  </code>
  <code code="C23">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1996-10-23"/>
  </code>
  <code code="C31">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1996-10-23"/>
  </code>
  <code code="CCAT">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1996-10-23"/>
  </code>
</codes>
<dc element="dc.date.created" value="1996-10-23"/>
<dc element="dc.publisher" value="Reuters Holdings Plc"/>
<dc element="dc.date.published" value="1996-10-23"/>
<dc element="dc.source" value="Reuters"/>
<dc element="dc.creator.location" value="MOUNTAIN VIEW, Calif"/>
<dc element="dc.creator.location.country.name" value="USA"/>
<dc element="dc.source" value="Reuters"/>
</metadata>
</newsitem>
